Rahul Rao is a freelance science writer, graduate of New York University’s Science, Health and Environmental Reporting Program, and “Doctor Who” fan.
Rahul Rao
From this contributor
Web app tracks pupil size in people, mice
The app relies on artificial intelligence and could help researchers standardize studies of pupil differences in autistic people and in mouse models of autism.
New library catalogs the human gut microbiome
Researchers put hundreds of gut bacteria strains through their paces to chart the compounds each creates — and to help others explore the flora's potential contribution to autism.
New unified toolbox traces, analyzes neurons
‘SNT’ helps researchers sift through microscope images to reconstruct and analyze neurons and their connections.
Explore more from The Transmitter
‘Overdue’ debate unfurls over neuroimaging method
After a January paper questioned the validity of an approach called lesion network mapping, its users are pressure testing their results.
‘Overdue’ debate unfurls over neuroimaging method
After a January paper questioned the validity of an approach called lesion network mapping, its users are pressure testing their results.
Nearly 400 compounds affect behaviors tied to autism-linked genes in zebrafish
Estropipate, paclitaxel and levocarnitine altered behaviors tied to SCN2A and DYRK1A variants specifically, a new open-source platform revealed.
Nearly 400 compounds affect behaviors tied to autism-linked genes in zebrafish
Estropipate, paclitaxel and levocarnitine altered behaviors tied to SCN2A and DYRK1A variants specifically, a new open-source platform revealed.
What neuroscientists want from a new NINDS director
The search is underway for the next director of the U.S. National Institute of Neurological Disorders and Stroke, who will face a range of challenges, neuroscientists say, but will also have an “immense opportunity to do good things.”
What neuroscientists want from a new NINDS director
The search is underway for the next director of the U.S. National Institute of Neurological Disorders and Stroke, who will face a range of challenges, neuroscientists say, but will also have an “immense opportunity to do good things.”